B+78/100

Is MercadoLibre Inc (MELI) a risky stock?

Sector: Retail Price: $1803.70 Composite: 78/100

As of July 21, 2026, Clavix grades MercadoLibre Inc (MELI) B+ for risk, a composite score of 78 out of 100 on an A+ to F scale, which puts MELI in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind MELI's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MELI scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
71
News sentimentscored, sourced recent coverage
65
Macro exposuresensitivity to rates, dollar, oil
68
Sector resiliencestrength vs the broad market
69
Price stabilitydrawdown and volatility
44

What's moving MELI's risk right now

Company-specific signals Clavix flags behind MELI's current grade, drawn from recent news and filings as of July 21, 2026.

Regulatory · mixed signal

John G Ullman & Associates Inc. purchased a new stake in shares of MercadoLibre, Inc. (NASDAQ:MELI - Free Report) during the 1st quarter, according to the company in its most rece…

Earnings & results · mixed signal

Journey Advisory Group LLC bought a new stake in MercadoLibre, Inc. (NASDAQ:MELI - Free Report) during the first quarter, HoldingsChannel reports. The firm bought 1,401 shares of…

Margins · mixed signal

The rally signals investor confidence in MELI's diversified growth strategy and its aggressive expansion into multiple verticals, potentially sustaining upward trend if executi…

What a B+ grade means

On the Clavix A+ to F scale, MELI's composite of 78 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MELI or any security. Grades are risk indicators, not predictions of return. Data may be delayed.